GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Euroespes SA (XMAD:EEP) » Definitions » YoY EBITDA Growth

Euroespes (XMAD:EEP) YoY EBITDA Growth : -152.73% (As of Dec. 2022)


View and export this data going back to 2011. Start your Free Trial

What is Euroespes YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Euroespes's YoY EBITDA Growth for the quarter that ended in Dec. 2022 was -152.73%.

Euroespes's EBITDA per Share for the six months ended in Dec. 2022 was €-0.03.


Euroespes YoY EBITDA Growth Historical Data

The historical data trend for Euroespes's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroespes YoY EBITDA Growth Chart

Euroespes Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -91.41 -309.09 186.96 185.00 -129.82

Euroespes Semi-Annual Data
Dec12 Jun13 Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 640.00 125.00 103.70 550.00 -152.73

Euroespes YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Euroespes's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(-0.017-0.057)/ | 0.057 |
=-129.82 %

Euroespes's YoY EBITDA Growth for the quarter that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (Q: Dec. 2022 )
=(EBITDA per Share (Q: Dec. 2022 )-EBITDA per Share (Q: Dec. 2021 )) / | EBITDA per Share (Q: Dec. 2021 )) |
=(-0.029-0.055)/ | 0.055 |
=-152.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Euroespes YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Euroespes's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroespes (XMAD:EEP) Business Description

Traded in Other Exchanges
N/A
Address
Santa Marta de Babio, Bergondo, La Coruna, ESP, 15165
Euroespes SA is a biomedical research center offering medical, research, medical informatics and bioinformatics services. It offers medicine and personalized treatment for central nervous system disorders and researches genomic medicine. Other services offered by the company include genomics, digital diagnosis, diagnostic imaging, neuro-psychology, neuro-ophthalmology, nursing, epigenetics, clinical analysis and otorhinolaryngology.